Patient perspectives on depot buprenorphine treatment for opioid addiction - a qualitative interview study
Abstract Background Recently developed buprenorphine depot injections have the potential to reduce risk for diversion and misuse, and to increase adherence with fewer visits for supervised intake. However, it is unclear how patients perceive this new form of medication. The purpose of this study was...
Saved in:
Main Authors: | Björn Johnson (Author), Olivia Liahaugen Flensburg (Author), Andrea Johansson Capusan (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study
by: Björn Johnson, et al.
Published: (2024) -
Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation
by: Ling W, et al.
Published: (2019) -
Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation [Corrigendum]
by: Ling W, et al.
Published: (2020) -
Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model
by: R. Ling, et al.
Published: (2022) -
New developments in managing opioid addiction: impact of a subdermal buprenorphine implant
by: Itzoe M, et al.
Published: (2017)